Enikő Sólyom

483 total citations
24 papers, 225 citations indexed

About

Enikő Sólyom is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Molecular Biology. According to data from OpenAlex, Enikő Sólyom has authored 24 papers receiving a total of 225 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 7 papers in Genetics and 6 papers in Molecular Biology. Recurrent topics in Enikő Sólyom's work include Cystic Fibrosis Research Advances (10 papers), Inhalation and Respiratory Drug Delivery (4 papers) and Antibiotic Resistance in Bacteria (3 papers). Enikő Sólyom is often cited by papers focused on Cystic Fibrosis Research Advances (10 papers), Inhalation and Respiratory Drug Delivery (4 papers) and Antibiotic Resistance in Bacteria (3 papers). Enikő Sólyom collaborates with scholars based in Hungary, United States and Germany. Enikő Sólyom's co-authors include Eszter Csiszér, B Koehler, Maria Ginalska-Malinowska, Jerzy Starzyk, T E Romer, Paul Saenger, F Péter, Mieczysław Walczak, K. Gyurkovits and Henryk Mazurek and has published in prestigious journals such as Genomics, International Immunology and Acta Paediatrica.

In The Last Decade

Enikő Sólyom

23 papers receiving 217 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Enikő Sólyom Hungary 8 74 54 52 46 34 24 225
Paul Dancey Canada 6 41 0.6× 21 0.4× 47 0.9× 30 0.7× 25 0.7× 14 220
Simone Schüller Austria 10 95 1.3× 16 0.3× 31 0.6× 77 1.7× 50 1.5× 13 308
René Liang Shen Denmark 12 146 2.0× 20 0.4× 35 0.7× 12 0.3× 36 1.1× 18 388
Alexandra Kent United Kingdom 7 24 0.3× 40 0.7× 16 0.3× 48 1.0× 48 1.4× 33 232
Halil Gürsoy Pala Türkiye 11 30 0.4× 21 0.4× 32 0.6× 50 1.1× 33 1.0× 57 369
Mario Vicino Italy 14 27 0.4× 26 0.5× 30 0.6× 66 1.4× 21 0.6× 36 700
V. Datta United Kingdom 7 20 0.3× 48 0.9× 49 0.9× 14 0.3× 16 0.5× 14 194
Amir Hakim United Kingdom 6 88 1.2× 27 0.5× 51 1.0× 60 1.3× 9 0.3× 13 322
Mark Oliver Australia 11 93 1.3× 54 1.0× 36 0.7× 20 0.4× 44 1.3× 25 275
Elvan Bayramoğlu Türkiye 10 19 0.3× 49 0.9× 56 1.1× 8 0.2× 23 0.7× 33 245

Countries citing papers authored by Enikő Sólyom

Since Specialization
Citations

This map shows the geographic impact of Enikő Sólyom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Enikő Sólyom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Enikő Sólyom more than expected).

Fields of papers citing papers by Enikő Sólyom

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Enikő Sólyom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Enikő Sólyom. The network helps show where Enikő Sólyom may publish in the future.

Co-authorship network of co-authors of Enikő Sólyom

This figure shows the co-authorship network connecting the top 25 collaborators of Enikő Sólyom. A scholar is included among the top collaborators of Enikő Sólyom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Enikő Sólyom. Enikő Sólyom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sólyom, Enikő, et al.. (2018). A pubertas fejlődését szabályozó neuroendokrin mechanizmusok. Irodalmi áttekintés. Orvosi Hetilap. 159(29). 1175–1182. 1 indexed citations
2.
Székely, Gyöngyi, et al.. (2014). Factors influencing quality of life and disease severity in Hungarian children and young adults with cystic fibrosis. ˜The œItalian Journal of Pediatrics/Italian journal of pediatrics. 40(1). 50–50. 21 indexed citations
3.
Székely, Gyöngyi, et al.. (2013). Quality of life in Hungarian patients with cystic fibrosis. Orvosi Hetilap. 154(20). 784–791. 3 indexed citations
4.
Székely, Gyöngyi, et al.. (2013). Cystás fibrosisban szenvedő betegek életminőségének felmérése Magyarországon | Quality of life in Hungarian patients with cystic fibrosis. 1 indexed citations
5.
Kovács, Márta, Mária Papp, Péter L. Lakatos, et al.. (2012). Low mannose-binding lectin (MBL) is associated with paediatric inflammatory bowel diseases and ileal involvement in patients with Crohn disease. Journal of Crohn s and Colitis. 7(2). 134–141. 10 indexed citations
6.
Kovács, Márta, Péter L. Lakatos, Mária Papp, et al.. (2012). Pancreatic Autoantibodies and Autoantibodies Against Goblet Cells in Pediatric Patients With Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition. 55(4). 429–435. 31 indexed citations
7.
Sólyom, Enikő, et al.. (2012). The effect of gonadotropin releasing hormone analogue therapy in girls with idiopathic central precocious puberty. Orvosi Hetilap. 153(11). 418–424. 5 indexed citations
8.
Minić, Predrag, Enikő Sólyom, Henryk Mazurek, et al.. (2011). 217* A multi-cycle open label study of nebulized liposomal amikacin (Arikace(tm)) in the treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection. Journal of Cystic Fibrosis. 10. S55–S55. 4 indexed citations
11.
Dupont, Lieven, Predrag Minić, Henryk Mazurek, et al.. (2008). A randomized placebo-controlled study of nebulized liposomal amikacin (Arikace™) in the treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection. Journal of Cystic Fibrosis. 7. S26–S26. 23 indexed citations
12.
Sólyom, J., et al.. (2007). Appropriate Sampling Times for Growth Hormone (GH) Measurement during Insulin Tolerance Testing (ITT) in Children. Hormone Research in Paediatrics. 68(5). 205–206. 3 indexed citations
13.
Romer, T E, F Péter, Paul Saenger, et al.. (2007). Efficacy and safety of a new ready-to-use recombinant human growth hormone solution. Journal of Endocrinological Investigation. 30(7). 578–589. 41 indexed citations
14.
Laki, Judit, Krisztína Németh, E. Endreffy, et al.. (2006). The 8.1 ancestral MHC haplotype is associated with delayed onset of colonization in cystic fibrosis. International Immunology. 18(11). 1585–1590. 30 indexed citations
15.
Sólyom, Enikő, et al.. (2006). [Prevalence of celiac disease in Turner syndrome].. PubMed. 147(25). 1185–8. 4 indexed citations
16.
Meinecke, Peter, Andrew E. Czeizel, László Tı́már, et al.. (2003). Disruption of the PDGFB gene in a 1;22 translocation patient does not cause Costello syndrome. Genomics. 83(5). 883–892. 3 indexed citations
17.
Endreffy, Emõke, Krisztína Németh, György Fekete, et al.. (2002). Molecular Genetic Diagnostic Difficulties in Two Hungarian Gypsy Samples with Cystic Fibrosis. International Journal of Human Genetics. 2(1). 41–44. 1 indexed citations
18.
Sólyom, Enikő, et al.. (1999). Lipid intake and serum cholesterol level in cystic fibrosis patients. Acta Alimentaria. 28(4). 371–378.
19.
Sólyom, Enikő, et al.. (1992). A new chromosomal translocation t/1;22/ /q25;q12/ in a 17-month-old girl.. PubMed. 32(1). 3–10. 1 indexed citations
20.
Sólyom, J., et al.. (1981). ‘DOT‐17α‐HYDROXYPROGESTERONE’ RADIOIMMUNOASSAY FOR IDENTIFICATION OF CONGENITAL ADRENAL HYPERPLASIA IN YOUNG INFANTS. Acta Paediatrica. 70(6). 913–917. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026